Latest Advances

  • Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • Published —
Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer
  • Journal: Anticancer research
  • Published —
Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy.
  • Condition: Recurrent Multifocal Brain Metastases of Small Cell Lung Cancer (SCLC)
  • Journal: Annals of palliative medicine
  • Treatment Used: Anlotinib Combined with Durvalumab After Definitive Concurrent Chemoradiotherapy and Palliative Radiotherapy
  • Number of Patients: 1
  • Published —
This case report describes the use of anlotinib combined with durvalumab in a patient with recurrent multifocal brain metastases of small cell lung cancer after definitive concurrent chemoradiotherapy and palliative radiotherapy of the lung and brain.
  • Condition: Chemotherapy Resistant/ Refractory Small-Cell Lung Cancer
  • Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Treatment Used: CAV (Cyclophosphamide, Doxorubicin, Vincristine) vs. Weekly Topotecan vs. Weekly Irinotecan
  • Number of Patients: 67
  • Published —
The aim of this study was to compare CAV (Cyclophosphamide, Doxorubicin, Vincristine), weekly topotecan, and weekly irinotecan regimens and to evaluate the effectiveness of each regimen in patients with chemotherapy resistant/refractory (CRR) small cell lung cancer (SCLC).
  • Condition: Extensive-Stage Small Cell Lung Cancer
  • Journal: Radiation oncology (London, England)
  • Treatment Used: Chemotherapy/Thoracic Radiotherapy
  • Number of Patients: 492
  • Published —
The study researched the outcomes of chemotherapy/thoracic radiotherapy for treating extensive-stage small cell lung cancer.
  • Condition: Small Cell Lung Cancer (SCLC)
  • Journal: Annals of palliative medicine
  • Treatment Used: Anti-PD-L1 Immune Checkpoint Inhibitor (PD-L1 Inhibitor) Combined with the Etoposide-Platinum (EP) Regimen for 6 Cycles
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patient with extensive-stage small cell lung cancer (highly malignant cancer that most commonly arises within the lung; SCLC) treated with anti-PD-L1 immune checkpoint inhibitor (PD-L1 inhibitor) combined with the etoposide-platinum (EP) regimen for 6 cycles.
  • Condition: Neuroendocrine Carcinoma of the Gallbladder
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Treatment Used: Chemotherapy and Radiation Therapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with neuroendocrine carcinoma of the gallbladder.
  • Condition: Relapsed Small Cell Lung Cancer
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Durvalumab and Tremelimumab with or without Stereotactic Body Radiation Therapy
  • Number of Patients: 18
  • Published —
This study compared the clinical outcome of using durvalumab and tremelimumab with or without stereotactic body radiation therapy to treat patients with relapsed small cell lung cancer.
  • Condition: Small Cell Lung Cancer
  • Journal: Annals of palliative medicine
  • Treatment Used: Immune Checkpoint Inhibitors
  • Number of Patients: 1981
  • Published —
This meta-analysis assessed the effectiveness and safety of immune checkpoint inhibitors for the treatment of small cell lung cancer (SCLC).
  • Condition: Extensive-Stage Small-Cell Lung Cancer
  • Journal: The Lancet. Oncology
  • Treatment Used: Durvalumab, with or without Tremelimumab, plus Platinum-Etoposide versus Platinum-Etoposide Alone
  • Number of Patients: 972
  • Published —
The study researched the outcomes of Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone for patients with extensive-stage small-cell lung cancer.
  • Condition: Lambert-Eaton Myasthenic Syndrome
  • Journal: Drugs of today (Barcelona, Spain : 1998)
  • Treatment Used: Amifampridine
  • Number of Patients: 136
  • Published —
This study tested the safety and efficacy of using amifampridine to treat patients with Lambert-Eaton myasthenic syndrome.
  • Condition: Small Cell Lung Cancer
  • Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Treatment Used: Irinotecan with Nedaplatin
  • Number of Patients: 64
  • Published —
The study researched the outcomes of irinotecan combined with nedaplatin for treating small cell lung cancer.
Showing 1-12 of 143